New hope for rare brain diseases: long-term safety trial of nizubaglustat begins
NCT ID NCT07399704
First seen Feb 16, 2026 · Last updated May 15, 2026 · Updated 10 times
Summary
This study tests the long-term safety and effects of a daily drug called nizubaglustat in people with two rare genetic diseases that affect the brain: GM2 gangliosidosis and Niemann-Pick type C. About 21 participants who were in an earlier study or who are currently on another drug (miglustat) will take nizubaglustat. Researchers will monitor side effects, seizures, and disease markers over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GM2 GANGLIOSIDOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Associação Hospitalar de Prot à Infância Dr. Raul Carneiro
RECRUITINGÁgua Verde, Curitiba, 80250-060, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hospital de Clinicas de Porto Alegre
RECRUITINGPorto Alegre, Rio Grande do Sul, 90035-903, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira
RECRUITINGRio de Janeiro, 22250, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.